Takeda Pharmaceuticals Co. Ltd. v. Zydus Pharmaceuticals Usa, Inc.
Takeda Pharmaceuticals Co. Ltd. v. Zydus Pharmaceuticals Usa, Inc.
Opinion
Case: 13-1089 Document: 9 Page: 1 Filed: 12/07/2012
NOTE: This order is nonprecedential.
United States Court of Appeals for the Federal Circuit __________________________
TAKEDA PHARMACEUTICALS COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS, LLC, TAKEDA PHARMACEUTICALS AMERICA, INC., AND ETHYPHARM, S.A., Plaintiffs-Appellees, v. ZYDUS PHARMACEUTICALS USA, INC. AND CADILA HEALTHCARE, LIMITED, Defendants-Appellants. __________________________
2013-1089 __________________________
Appeal from the United States District Court for the District of New Jersey in case no. 10-CV-1723, Judge Joel A. Pisano. __________________________
ON MOTION __________________________
ORDER The appellants move to expedite briefing and argu- ment. Upon consideration thereof, Case: 13-1089 Document: 9 Page: 2 Filed: 12/07/2012
TAKEDA PHARMACEUTICALS CO. V. ZYDUS PHARMACEUTICALS 2 USA IT IS ORDERED THAT: (1) The motion to expedite briefing is granted to the following extent: The appellants' opening brief is due December 17. The appellees' brief is due January 2, 2013. The appellants' reply brief and the joint appendix are due January 9, 2013. (2) Oral argument will be scheduled by subsequent order of the court. FOR THE COURT
/s/ Jan Horbaly Jan Horbaly Clerk s8
Reference
- Status
- Unpublished